Literature DB >> 33619181

Guidelines to understand and compute the number needed to treat.

Valentin Vancak1, Yair Goldberg2, Stephen Z Levine3.   

Abstract

OBJECTIVE: We aim to explain the unadjusted, adjusted and marginal number needed to treat (NNT) and provide software for clinicians to compute them.
METHODS: The NNT is an efficacy index that is commonly used in randomised clinical trials. The NNT is the average number of patients needed to treat to obtain one successful outcome (ie, response) due to treatment. We developed the nntcalc R package for desktop use and extended it to a user-friendly web application. We provided users with a user-friendly step-by-step guide. The application calculates the NNT for various models with and without explanatory variables. The implemented models for the adjusted NNT are linear regression and analysis of variance (ANOVA), logistic regression, Kaplan-Meier and Cox regression. If no explanatory variables are available, one can compute the unadjusted Laupacis et al's NNT, Kraemer and Kupfer's NNT and the Furukawa and Leucht's NNT. All NNT estimators are computed with their associated appropriate 95% confidence intervals. All calculations are in R and are replicable.
RESULTS: The application provides the user with an easy-to-use web application to compute the NNT in different settings and models. We illustrate the use of the application from examples in schizophrenia research based on the Positive and Negative Syndrome Scale. The application is available from https://nntcalc.iem.technion.ac.il. The output is given in a journal compatible text format, which users can copy and paste or download in a comma-separated values format.
CONCLUSION: This application will help researchers and clinicians assess the efficacy of treatment and consequently improve the quality and accuracy of decisions. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  schizophrenia & psychotic disorders

Mesh:

Year:  2021        PMID: 33619181     DOI: 10.1136/ebmental-2020-300232

Source DB:  PubMed          Journal:  Evid Based Ment Health        ISSN: 1362-0347


  3 in total

1.  Capturing adolescents in need of psychiatric care with psychopathological symptoms: A population-based cohort study.

Authors:  Anat Rotstein; Judy Goldenberg; Suzan Fund; Stephen Z Levine; Abraham Reichenberg
Journal:  Eur Psychiatry       Date:  2021-11-29       Impact factor: 5.361

2.  PAX-D: study protocol for a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depression.

Authors:  Sheena Kristine Au-Yeung; James Griffiths; Sophie Roberts; Chloe Edwards; Ly-Mee Yu; Rafal Bogacz; Jennifer Rendell; Mary-Jane Attenburrow; Stuart Watson; Fiona Chan; Andrea Cipriani; Anthony Cleare; Catherine J Harmer; David Kessler; Jonathan Evans; Glyn Lewis; Ilina Singh; Judit Simon; Paul J Harrison; Phil Cowen; Milensu Shanyinde; John Geddes; Michael Browning
Journal:  Evid Based Ment Health       Date:  2021-11-22

3.  The number needed to treat adjusted for explanatory variables in regression and survival analysis: Theory and application.

Authors:  Valentin Vancak; Yair Goldberg; Stephen Z Levine
Journal:  Stat Med       Date:  2022-04-26       Impact factor: 2.497

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.